Maxivision Super Specialty Eye Hospitals partners with Ojas Group in Maharashtra, investing Rs 500 crore to expand operations and provide high-quality eye care.

GSK PLC (GSK) reports robust sales and profit growth, while navigating external pressures in the vaccine market and preparing for future product approvals.

The report provides insights into GSK's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

GlaxoSmithKline is to team up with two UK ... is just one of a new generation of public-private partnerships in drug discovery being set up across the world. But the scale and depth of this ...

Chief Commercial Officer Luke Miels explained that while near-term challenges persist, the partnership with Zhifei positions GSK for long-term success. Richard Parkes, BNPP Exane: Inquired about ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

GSK has made a $70 million down payment to expand the partnership, with an undisclosed minimum financial commitment over three years that can be extended to five if desired. Image Phil Taylor ...

This partnership represents a step forward in cancer research Professor Irene Tracey, University of Oxford Tony Wood, chief scientific officer at GSK, said: “We’re pleased to further ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore the potential of cancer prevention through vaccination. The partnership, ...